
Patients with COVID-19 in the ICU safely and effectively received direct oral challenges for low-risk and unverified penicillin allergies, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.
These challenges could clear patients to receive more effective antibiotics against ventilator-associated pneumonia and other common bacterial superinfections among patients with COVID-19 in the ICU, the researchers said.
“Many critically ill patients with COVID-19 have high severity of illness and prolonged ICU and hospital lengths of stay, resulting in the